Disclosure 16942
Publication date:
Last updated:
Summary
| Issuer |
SKAN Group AG |
| Reason for disclosing |
Acquisition
|
| Basis of calculation |
10’471’530 |
| Purchase positions |
5’844’037
(55.809%)
|
| Sale positions |
0
(0.000%)
|
| Date of origination of the reporting obligation |
19.02.2014
|
Individual shareholder
| Beneficial owner |
Dr. h.c. Willy Michel, c/o Techpharma Management AG, 3400 Burgdorf |
| Direct shareholder |
|
Purchase positions
Namenaktien
| Number |
Voting rights |
| 5’844’037 |
5’844’037 |
No voting rights at own discretion
